These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28626504)

  • 1. Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis.
    Olufade T; Kong AM; Princic N; Juneau P; Kulkarni R; Zhang K; Datto C
    Am Health Drug Benefits; 2017 Apr; 10(2):79-86. PubMed ID: 28626504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Burden of Healthcare Utilization and Cost Associated with Opioid-Related Constipation Among Patients with Noncancer Pain.
    Fernandes AW; Kern DM; Datto C; Chen YW; McLeskey C; Tunceli O
    Am Health Drug Benefits; 2016 May; 9(3):160-70. PubMed ID: 27606040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of opioid-induced constipation among long-term opioid users with noncancer pain.
    Wan Y; Corman S; Gao X; Liu S; Patel H; Mody R
    Am Health Drug Benefits; 2015 Apr; 8(2):93-102. PubMed ID: 26005516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy.
    Fine PG; Chen YW; Wittbrodt E; Datto C
    Support Care Cancer; 2019 Feb; 27(2):687-696. PubMed ID: 30056531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
    Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
    Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients.
    Landsman-Blumberg PB; Katz N; Gajria K; D'Souza AO; Chaudhari SL; Yeung PP; White R
    J Pain Res; 2017; 10():1713-1722. PubMed ID: 28769587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: a retrospective claims database analysis.
    As-Sanie S; Soliman AM; Evans K; Erpelding N; Lanier R; Katz NP
    J Med Econ; 2020 Apr; 23(4):371-377. PubMed ID: 31856613
    [No Abstract]   [Full Text] [Related]  

  • 9. Healthcare resource use and costs of opioid-induced constipation among non-cancer and cancer patients on opioid therapy: A nationwide register-based cohort study in Denmark.
    Søndergaard J; Christensen HN; Ibsen R; Jarbøl DE; Kjellberg J
    Scand J Pain; 2017 Apr; 15():83-90. PubMed ID: 28850356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients.
    Pergolizzi JV; Ma L; Foster DR; Overholser BR; Sowinski KM; Taylor R; Summers KH
    J Manag Care Spec Pharm; 2014 May; 20(5):467-76. PubMed ID: 24761818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in healthcare utilization and associated costs between patients prescribed vs. nonprescribed opioids during an inpatient or emergency department visit.
    Xie L; Joshi AV; Schaaf D; Mardekian J; Harnett J; Shah ND; Baser O
    Pain Pract; 2014 Jun; 14(5):446-56. PubMed ID: 23809064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world assessment of concomitant opioid utilization and associated trends in patients with migraine.
    Kangethe A; Polson M; Evangelatos TM; Speicher LC; Tenaglia AT; Staats PS; Liebler EJ; Mwamburi M
    Am J Manag Care; 2020 Feb; 26(1 Suppl):S8-S14. PubMed ID: 32109019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery.
    Wittbrodt ET; Gan TJ; Datto C; McLeskey C; Sinha M
    J Pain Res; 2018; 11():1017-1025. PubMed ID: 29881304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns, healthcare utilization, and costs of chronic opioid treatment for non-cancer pain in the United States.
    Kern DM; Zhou S; Chavoshi S; Tunceli O; Sostek M; Singer J; LoCasale RJ
    Am J Manag Care; 2015 Mar; 21(3):e222-34. PubMed ID: 26014310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer pain.
    Ivanova JI; Birnbaum HG; Yushkina Y; Sorg RA; Reed J; Merchant S
    J Opioid Manag; 2013; 9(4):239-54. PubMed ID: 24353017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of treatment failure amongst patients with irritable bowel syndrome with constipation or chronic constipation: a retrospective analysis of a Medicaid population.
    Guerin A; Carson RT; Lewis B; Yin D; Kaminsky M; Wu E
    J Med Econ; 2014 Aug; 17(8):577-86. PubMed ID: 24811855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.
    Shah A; Xie L; Kariburyo F; Zhang Q; Gore M
    Adv Ther; 2018 Nov; 35(11):1994-2014. PubMed ID: 30269292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.